ASTRAZENECA PHARMA Surges by 5%; BSE HEALTHCARE Index Up 1.3%

Wed, 25 Mar 02:47 PM

ASTRAZENECA PHARMA share price has zoomed 5% and is presently trading at Rs 2,177.

Meanwhile, the BSE HEALTHCARE Index is at 11,460 (up 1.3%).

Among the top Gainers in the BSE HEALTHCARE Index today are ASTRAZENECA PHARMA (up 5.1%) and DR. LAL PATHLABS LTD (up 5.3%).

NATCO PHARMA (down 0.2%) and CIPLA (down 0.2%) are among the top losers today.

Over the last one year, ASTRAZENECA PHARMA has moved up from Rs 1,968 to Rs 2,177, registering a gain of Rs 209 (up 8.8%).

On the other hand, the BSE HEALTHCARE has moved down from 14,114 to 11,460, loss of 2,654 points (down 19.2%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 92.2%), J.B.CHEMICALS (up 51.0%) and IPCA LABS (up 42.1%).

JUST IN: Limited-Time Access to Full Transcript of Our Urgent Broadcast on India's Revival

What About the Benchmark Indices?

The BSE Sensex is at 28,790 (up 7.1%).

The top gainers among the BSE Sensex stocks today are RELIANCE IND. (up 18.5%), KOTAK MAHINDRA BANK (up 13.4%) and HDFC BANK (up 9.5%). Other gainers include MARUTI SUZUKI (up 8.9%) and AXIS BANK (up 8.5%). The most traded stocks in the BSE Sensex are RELIANCE IND. and SBI.

In the meantime, NSE Nifty is at 8,377 (up 6.6%). The top gainers in the NSE Nifty include RELIANCE IND. (up 17.1%), KOTAK MAHINDRA BANK (up 12.4%) and UPL (up 10.0%). Other gainers include GRASIM (up 9.5%) and HDFC BANK (up 9.3%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved down from 37,809 to 28,790, registering a loss of 9,019 points (down 24.44%).

ASTRAZENECA PHARMA Financial Update...

ASTRAZENECA PHARMA net profit down at Rs 144 million for the quarter ended September 2019, compared to a loss of Rs 291 million a year ago. Net Sales declined 3.1% to Rs 2.1 billion during the period as against Rs 2.2 billion in July-September 2018.

For the year ended March 2018, ASTRAZENECA PHARMA reported 29.2% increase in net profit to Rs 259.0 million compared to net profit of Rs 200.0 million during FY17.

Revenue of the company grew 4.3% to Rs 6 billion during FY18.

The current Price to earnings ratio of ASTRAZENECA PHARMA, based on rolling 12 month earnings, stands at 71.5x.

Indian Share Market Update: Top Gainers and Losers

What else is happening in the markets today? Dig in...